On October 9, 2026, Mark Zuckerberg's Biohub announced a $1.8 billion biological data initiative with Google and the U.S. government, aimed at building the largest open biological dataset ever assembled to train AI models on entire cells rather than just protein biology. Reporting since has named Meta, Google DeepMind and Isomorphic Labs as partners, and Biohub says it hopes to expand the effort to pharma companies. The newest thread is access: commercial funders get a 12-month embargo on the data before it becomes open, which sits against the open-data framing and leaves the terms for industry partners unsettled.